Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MultiplexDX International logo — Eliminating cancer misdiagnosis by launching a new diagnosti...

MultiplexDX International

Eliminating cancer misdiagnosis by launching a new diagnostic test in 2023 and operating a boutique oligo house.

Founded 2015 United States Rockville, United States 37 employees Grant Total: $1.20M Biotechnology, Health Care +1

General Information

Company Name MultiplexDX International
Founded Year 2015
Location United States Rockville, United States
Employees 37
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with MultiplexDX International. To contact MultiplexDX International, visit multiplexdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MultiplexDX International compare?

A PDF of MultiplexDX International and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MultiplexDX International soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MultiplexDX International

MultiplexDX Inc. is an international corporation established in 2015 with units in both Maryland, US, and Slovakia. The company's slogan is "Eliminating cancer misdiagnosis by launching a new diagnostic test in 2023 and operating a boutique oligo house." MultiplexDX aims to achieve this by introducing a 98% accurate, quantitative, and accessible diagnostic test to eliminate cancer misdiagnosis. Additionally, the company operates a boutique oligohouse offering highly specialized custom oligonucleotides to the research community. The mission of MultiplexDX is to transform breast cancer treatment non-responders into responders, ensuring durable responses and aiming to drastically increase survival rates by at least 50%. This ambitious mission is supported by several objectives, including the development of technologies and products for molecular diagnostic markets superior to currently available products, core facility services using proprietary Multiplex TM technology, and the development of hi-tech 3D digital pathology services. The company's last investment was a grant investment received on 24 September 2019 from IPA4SME. MultiplexDX operates in the biotechnology and pharmaceutical industries and is headquartered in the United States. For more information about MultiplexDX, you can visit their official website and follow them on social media: - Website: www.multiplexdx.com - Facebook: MultiplexDX on Facebook - Twitter: MultiplexDX on Twitter - Google Plus: MultiplexDX on Google Plus - YouTube: MultiplexDX on YouTube

Business keywords: biotech diagnostics, cancer diagnostics, molecular diagnostic tests, oligonucleotides, breast cancer treatment, quantitative diagnostic tests, 3D digital pathology services, molecular biology, histopathological methods, visualization technology, medical diagnostics, prognostic methods, oncology, technology development, medical research

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
IPA4SME
24 Sep 2019
Venture Round €1.20M 3
Neulogy Ventures
Neulogy Ventures, Ronald Cook +1
04 Oct 2018
Venture Round Undisclosed 1
Neulogy Ventures
Neulogy Ventures
28 Oct 2016
Seed Round Undisclosed 1
Neulogy Ventures
Neulogy Ventures
01 Feb 2016

MultiplexDX International Alternatives & Competitors

View All Alternatives
MultiplexDX International vs
Metamark Genetics
Metamark Genetics United States

Metamark - A leader in comprehensive urology cancer care

Growth
23 employees
Biotechnology, Health Care
Compare MultiplexDX International vs Metamark Genetics
MultiplexDX International vs
Theoria Science
Theoria Science

Specializing in exosome research, pioneering cancer diagnostics and treatments, and excelling in ins...

Venture round
Biotechnology, Care Economy
Compare MultiplexDX International vs Theoria Science
MultiplexDX International vs
OncoDiag
OncoDiag

Innovative Solutions for Cancer Diagnostics

Series A
6 employees
Biotechnology, Health Care
Also compare with: MultiplexDX International vs Amadix Amadix View all alternatives

FAQ About MultiplexDX International

Eliminating cancer misdiagnosis by launching a new diagnostic test in 2023 and operating a boutique oligo house.
MultiplexDX International was founded in 2015.
MultiplexDX International is headquartered in Rockville, United States.
MultiplexDX International operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on biotech diagnostics, cancer diagnostics, molecular diagnostic tests and oligonucleotides.
MultiplexDX International has approximately 37 employees.
MultiplexDX International has completed 4 funding rounds, raising a total of $1.20M. The latest funding stage is Grant.
Top alternatives and competitors to MultiplexDX International include Metamark Genetics, Theoria Science, OncoDiag, Atossa Therapeutics, Bound Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MultiplexDX International and Metamark Genetics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MultiplexDX International, https://bouncewatch.com/company/multiplexdx-inc, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes